In a 2023 survey of over 8,600 microdosers published in Scientific Reports, roughly 75% of respondents reported improvements in mood and wellbeing over a 30-day tracking period. That is an encouraging number. It is also self-reported, uncontrolled, and subject to expectancy bias. This tension between promise and proof runs through everything we currently know about microdosing psilocybin, and it is exactly where an honest guide should begin.
This article is designed to be the resource you read before your first microdose and the one you return to as your practice evolves. It covers what microdosing is, what the research does and does not support, how to approach it safely, and how to build a reflective, sustainable practice. No hype. No guarantees. Just the clearest picture we can offer right now.
What Microdosing Actually Is (and What It Is Not)
Microdosing involves taking a sub-perceptual dose of a psychedelic substance, most commonly psilocybin mushrooms or LSD. Sub-perceptual is the key word: a true microdose should not produce hallucinations, significant alterations in perception, or anything that would interfere with your ability to go about your day. If you feel noticeably "high," you have likely taken too much.
This is fundamentally different from recreational use or macrodosing (the full psychedelic experience). Macrodoses involve 2 to 5 grams of dried psilocybin mushrooms and produce profound shifts in consciousness. A microdose typically involves one-tenth to one-twentieth of that amount, taken on a structured schedule over weeks or months.
It is worth being upfront about what microdosing is not. It is not a productivity hack, despite what some corners of Silicon Valley might suggest. It is not a cure for depression, anxiety, or any other condition. And it is not a shortcut to anything. The people who seem to benefit most from microdosing tend to approach it as a practice: intentional, reflective, and paired with other forms of self-care. Think of it less like taking a supplement and more like beginning a new form of self-observation.
What the Evidence Currently Supports
The research on microdosing psilocybin is growing rapidly, but honesty demands we acknowledge where it stands. Most of the evidence comes from three types of studies: large observational surveys, open-label trials (where participants know they are taking a psychedelic), and a small but increasing number of placebo-controlled studies.
The observational data is largely positive. A 2019 systematic review by Kuypers et al. in Journal of Psychopharmacology found that microdosers commonly reported improvements in mood, creativity, and focus. The study mentioned earlier tracked thousands of microdosers alongside non-microdosers and found small but consistent advantages in mood and mental health scores.
However, the controlled research is more complicated. A well-designed 2021 study by Szigeti et al. published in eLife used an innovative self-blinding method with 191 participants and found that while microdosers did report psychological benefits, these improvements were not significantly different from the placebo group. This does not mean microdosing "doesn't work." It means expectancy, the belief that something will help, is a powerful force, and we cannot yet cleanly separate it from the effects of psilocybin itself.
More recent controlled trials, including a 2022 randomised trial by Cavanna et al. published in Translational Psychiatry, have found some measurable effects on emotional processing and creativity tasks, though effect sizes remain modest. The evidence is best described as evidence-informed rather than conclusive. For a deeper look at how psilocybin interacts with the brain at sub-perceptual doses, see our article on the neuroscience of microdosing.
Before You Begin: Safety and Suitability
Microdosing is not suitable for everyone. Before you begin, it is worth taking an honest look at your current health, your mental health history, and any medications you may be taking. This is not a formality. Certain conditions and medications interact with psilocybin in ways that can carry real risk.
Pre-start checklist: Before beginning a microdosing practice, consider your mental health history (personal and family), current medications (especially SSRIs, lithium, and other serotonergic drugs), any cardiac conditions, and whether you are in a stable life situation that supports self-experimentation. If any of these areas raise questions, speak with a healthcare provider first.
Contraindications and Medication Interactions
Psilocybin acts primarily on serotonin receptors, and this means it can interact unpredictably with other substances that affect the serotonin system. If you have a personal or family history of psychosis or bipolar disorder, most experts in the psychedelic research community advise against microdosing. The risk of triggering or exacerbating psychotic symptoms, even at low doses, is not well enough understood to be taken lightly.
SSRIs and other antidepressants present a more nuanced picture. Some interactions may simply blunt the effects of psilocybin, while others raise concerns about serotonin syndrome, a rare but potentially serious condition. We have written extensively about microdosing and SSRIs and broader medication interactions. If you are currently taking any psychiatric medication, consult your prescribing healthcare provider before starting a microdosing practice. Do not adjust or stop medication on your own.
Cardiac considerations also deserve attention. Psilocybin's activity at the 5-HT2B receptor has raised theoretical concerns about heart valve effects with long-term use. For a thorough discussion, see our article on microdosing and heart health. For a complete overview of who should approach microdosing with caution or avoid it entirely, read our full contraindications guide.
Legal Status: Know Your Jurisdiction
Psilocybin's legal status varies significantly around the world. In many countries and jurisdictions, it remains a controlled substance. Some regions have decriminalised possession or are exploring regulated therapeutic access, but decriminalisation is not the same as legalisation. Before beginning any practice involving psilocybin, make sure you understand the laws that apply where you live. Our article on the legal landscape of psilocybin covers the current state of affairs in more detail.
Setting Your Intention
Intention is not a mystical concept. It is simply getting clear on why you are doing this. People who microdose report a wide range of motivations: exploring greater emotional flexibility, supporting creative work, cultivating focus, or simply becoming more curious about their inner life. None of these are medical claims. They are directions of attention.
Setting an intention matters because it gives you something to observe against. Without it, microdosing can become another thing you do on autopilot, and autopilot is precisely the mode of being that many microdosers are trying to step back from.
An evidence-informed approach to intention draws on Acceptance and Commitment Therapy (ACT), a framework developed in clinical psychology that emphasises values-driven action and psychological flexibility. Rather than setting a goal like "fix my anxiety," an ACT-informed intention might be "notice when I feel anxious and stay present with it, rather than immediately pulling away." This is not about forcing outcomes. It is about orienting your attention toward what matters to you and then observing honestly what happens.
Afterglow's journaling framework was developed with Dr. Edmund Neuhaus of Harvard Medical School and is built around this ACT-informed approach. But whatever tools you use, the principle is the same: begin with a clear, honest question rather than a predetermined answer.
Understanding Dose: Finding Your Sub-Perceptual Range
The typical microdose range cited in research literature is roughly 50 to 300mg of dried psilocybin mushrooms, with most people finding their effective range somewhere between 100 and 200mg. This is a broad window for a good reason: psilocybin content varies between mushroom species, between individual mushrooms of the same species, and even between different parts of the same mushroom.
Sub-perceptual means you should not feel any obvious psychoactive effects. You are not looking for visuals, body heaviness, or altered thinking. Some people report a very subtle shift in mood or sensory awareness, but even this is not guaranteed or necessary. Many experienced microdosers describe the ideal dose as "noticing nothing in the moment, but noticing something different over time."
Start at the low end. If you are new to this, 50 to 100mg is a reasonable beginning. You can always increase by small increments in future sessions. Starting too high risks an uncomfortable experience and undermines the whole point of a sub-perceptual practice. Consistency of your material also matters. For guidance on storage and preparation, including why homogenising your supply can reduce dose variability, see our dedicated article.
Why Doses Vary Between People
Two people taking the same weighed amount of the same mushroom can have meaningfully different experiences. Body weight plays a role, though it is not as straightforward as with many pharmaceuticals. Individual sensitivity to serotonergic compounds varies. Gut health and metabolism may also contribute, though research here is very early.
People on certain medications may find that their effective threshold is different, sometimes higher (as with SSRIs blunting effects), sometimes unpredictable. This is another reason why cautious self-titration matters. If your first dose produces effects that feel too strong, perceptual shifts, anxiety, or significant mood changes, reduce your dose next time. Our guide on what to do if effects feel too strong covers this in more detail.
Choosing a Protocol
A protocol is simply a schedule that structures when you microdose and when you rest. Three main approaches dominate the conversation.
The Fadiman protocol, named after psychedelic researcher James Fadiman, follows a cycle of one day on, two days off. Day one is your microdose day. Day two is a transition day where you observe any residual or aftereffect. Day three is a baseline day. Then you repeat. This protocol is popular among beginners because the rest days help you distinguish between microdose effects and your normal baseline.
The Stamets stack, proposed by mycologist Paul Stamets, involves four consecutive days on followed by three days off, often combined with lion's mane mushroom and niacin. The rationale involves proposed neurogenic effects, though controlled evidence for this specific combination is limited. Some people report that consecutive dose days build a subtle momentum, while others find it tips them past the sub-perceptual threshold.
Intuitive or self-directed protocols involve dosing when you feel it is appropriate, without a fixed schedule. This can work well for experienced microdosers who have developed strong self-awareness, but it carries a higher risk of confirmation bias and inconsistent practice for beginners.
No protocol has been proven superior to any other. The Fadiman protocol vs Stamets stack debate is ultimately a matter of personal fit, not scientific hierarchy. For a detailed comparison, including practical considerations for choosing between them, read our article on comparing microdosing protocols.
Track your protocol with intention. Afterglow's protocol tracker helps you stay consistent and notice what's actually changing.
Your First Microdose Day: What to Expect
Take your first microdose on a day when you have no major obligations. Not because you are likely to feel impaired, but because you want to give yourself the space to observe without pressure. A quiet Saturday or a day off work is ideal.
Take your dose in the morning, ideally with a light meal to reduce the chance of nausea. Then go about your day. Do not sit and wait for something to happen. The whole point of a sub-perceptual dose is that it should not announce itself. Go for a walk. Do some light work. Spend time with a hobby.
What you should feel: possibly nothing at all, and that is perfectly fine. Some people report a very mild uplift in mood, a slight increase in sensory richness (colours seeming a touch more vivid, music sounding slightly more engaging), or a gentle sense of presence. These are subtle observations, not dramatic shifts.
What you should not feel: visual disturbances, significant anxiety, confusion, a noticeable body high, or anything that would make you uncomfortable driving or having a conversation. If you experience any of these, your dose was likely too high. Do not panic. These effects typically resolve within a few hours. Read our article on what to do if effects feel too strong for practical guidance.
Effects from a psilocybin microdose generally onset within 30 to 60 minutes, if perceptible at all, may last 3 to 5 hours. Many people report that on-days feel unremarkable in the moment but that they notice something subtly different when they reflect at the end of the day.
The Role of Journaling and Reflection
If there is one thing that separates a thoughtful microdosing practice from just taking a substance and hoping for the best, it is tracking. The effects of microdosing are, by definition, subtle. Without some form of structured observation, it is remarkably easy to see what you want to see or to miss genuine shifts because they do not match your expectations.
Confirmation bias is the biggest risk here. You take a microdose, you have a good day, and you credit the dose. You have a bad day and you dismiss it as unrelated. Over weeks, you construct a narrative that may or may not reflect reality. Journaling interrupts this pattern by creating a record you can actually look back on.
What is worth tracking? Mood (not just good or bad, but the texture of your emotional landscape). Energy levels throughout the day. Sleep quality and duration. Focus and cognitive clarity. Social ease or withdrawal. Physical sensations, including any discomfort. Creative engagement. And crucially: track these on off-days as well as on-days. Your baseline matters just as much as your microdose days.
Afterglow was built specifically for this kind of reflective practice. Its journaling features include ACT-informed prompts designed with Dr. Edmund Neuhaus, and its pattern recognition helps surface trends across weeks and months that you might not spot in daily entries. But whether you use an app, a spreadsheet, or a paper notebook, the practice of regular, honest reflection is what makes the difference.
Recognising Patterns Over Time
The most meaningful observations from microdosing tend to emerge over weeks, not days. A single entry that says "felt more creative today" tells you very little. Thirty entries that show a consistent pattern of increased creative engagement on dose days and the day after, compared to baseline days, starts to become interesting.
Look for subtle shifts in emotional flexibility: do you find yourself responding to frustration with a little more space? Creative engagement: are ideas flowing more freely during certain periods? Relational ease: are conversations feeling different? These are the kinds of changes that many microdosers report, and they are exactly the kinds of changes that are easy to miss without structured reflection.
Distinguishing signal from noise takes time and honest data. This is where structured journaling tools become most valuable, not because they tell you what to think, but because they help you see what is actually there.
Common Side Effects and How to Respond
Microdosing is generally well-tolerated, but it is not side-effect-free. Commonly reported side effects include mild nausea (especially on an empty stomach), transient changes in energy (either heightened or slightly fatigued), increased emotional sensitivity, and occasional sleep disruption if the dose is taken too late in the day.
None of these are inherently alarming, but none should be dismissed either. Mild nausea often resolves with a lighter starting dose or by taking the microdose with food. Emotional sensitivity can actually be useful information if you are tracking your inner experience, though it can also be uncomfortable. If you find that microdosing consistently disrupts your sleep, try taking your dose earlier in the day. For more on this, see our article on sleep and rest.
For a fuller discussion of side effects, including some that are not commonly talked about, read our article on microdosing side effects nobody talks about.
Microdosing and Tolerance
Psilocybin tolerance develops quickly. At sub-perceptual doses, the tolerance picture is less clear, but the principle holds: rest days are not optional decoration. They are built into every major protocol for a reason.
Signs you may be developing tolerance include needing to increase your dose to notice the same subtle effects, a general flatness or sense that the practice has "stopped working," or feeling like dose days and off-days are indistinguishable. If this happens, a longer break, typically one to two weeks, can help reset your sensitivity. Some protocols recommend a full month off after every six to eight weeks of microdosing.
When to Adjust, Pause, or Stop
Knowing when to stop is just as important as knowing how to start. Microdosing is a practice, and like any practice, it should serve you. If it is not serving you, stepping back is not a failure. It is the most self-aware response you can have.
Consider adjusting your dose or protocol if you are experiencing persistent side effects, if the practice feels like it is adding stress rather than supporting you, or if you are finding it difficult to tell whether microdosing is doing anything at all.
Consider pausing or stopping if you notice increased anxiety that correlates with dose days, mood instability or emotional swings that feel unmanageable, persistent physical discomfort (headaches, gastrointestinal issues, chest tightness), or if you have given the practice a reasonable period (most researchers suggest at least four to six weeks of consistent practice) and you genuinely are not observing any benefit.
Stopping is always an option. Psilocybin is not physically addictive, and there is no withdrawal process. If something feels wrong, trust that feeling. You can always revisit microdosing later, under different circumstances, or not at all. For more guidance, read our article on what to do when microdosing isn't working.
Special Considerations
Certain populations face additional considerations when it comes to microdosing. These are covered in depth in their own articles, but they deserve a brief mention here.
People on Medication
If you are currently taking any medication, particularly psychiatric medication, do not begin microdosing without consulting your healthcare provider. This is not a boilerplate warning. SSRIs, MAOIs, lithium, and other serotonergic drugs can interact with psilocybin in ways that range from simply reducing its effects to posing genuine health risks. Our articles on microdosing and SSRIs and medication interactions provide a detailed evidence-informed overview, but they are not a substitute for personalised medical advice.
Women and Hormonal Cycles
This is an area where formal research is almost entirely absent, but anecdotal reports are consistent enough to warrant attention. Some women who microdose report that their sensitivity to psilocybin varies across their menstrual cycle, with heightened effects during certain phases (commonly the luteal phase or around menstruation). Perimenopause and menopause have also emerged as areas of anecdotal interest, with some women reporting that microdosing supports emotional regulation during hormonal transitions.
None of this constitutes evidence. It constitutes a pattern worth paying attention to. If you menstruate, cycle-aware tracking, noting where you are in your cycle alongside your microdose journal entries, can help you identify whether hormonal fluctuations affect your experience. This is exactly the kind of subtle, personalised pattern that structured journaling is designed to surface.
People Exploring Microdosing for Focus and ADHD
Interest in microdosing as a support for focus and attention, including among people with ADHD diagnoses, has grown significantly. A 2023 survey-based study by Hutten et al. in Psychopharmacology found that some microdosers reported subjective improvements in focus and cognitive function, but controlled studies specifically examining a microdosing ADHD protocol are essentially nonexistent.
This is an area where the gap between anecdotal reports and controlled evidence is especially wide. If you are considering microdosing in relation to ADHD, approach it with clear expectations and honest tracking, and do not adjust any existing ADHD medication without consulting your healthcare provider. Our article on microdosing for ADHD: what we know and what we don't offers a thorough, balanced overview.
Building a Sustainable Practice
A sustainable microdosing practice is one that includes regular breaks. Most experienced microdosers cycle on and off, following a protocol for four to eight weeks and then taking a break of two to four weeks before deciding whether to continue. This approach respects the tolerance question, allows you to reassess your baseline, and avoids the trap of indefinite use without reflection.
It also helps to think of microdosing as one thread in a larger tapestry of wellbeing, not the whole cloth. Many people who report positive experiences with microdosing also engage in other practices: meditation, regular exercise, therapy, creative pursuits, time in nature, or meaningful social connection. It is often difficult, and perhaps unnecessary, to attribute improvements to any single practice. What matters is whether the overall fabric of your life is moving in a direction you value.
You don't have to figure this out alone. Afterglow's community offers a grounded space for ongoing reflection, honest questions, and shared experience from people navigating the same practice.
Integration is a word borrowed from the macrodose psychedelic world, but it applies to microdosing too. It means taking what you notice during your practice and actively working with it. If journaling reveals that you are consistently more patient on dose days, the question becomes: what can you learn from that patience? Can you cultivate it on off-days too? Can you bring it into relationships or work? The substance opens a window. What you do with the view is up to you.
A Note on Expectations and Honesty
The internet is full of microdosing success stories. People credit it with saving their marriages, transforming their careers, and resolving lifelong emotional struggles. Some of those stories may be entirely genuine. Some are likely shaped by expectancy, enthusiasm, and the very human desire to find a solution.
The less-told story is the one where someone microdoses for six weeks, tracks carefully, and concludes that it did not do much for them. This outcome is also valid. It does not mean they did it wrong. It means this particular practice, at this particular time, was not the thing they needed. The research suggests that microdosing does something for some people under some conditions. That is a far cry from "it works for everyone," and pretending otherwise does a disservice to anyone considering it.
The most honest approach to microdosing is one rooted in curiosity rather than certainty. Track what happens. Notice what you notice. Be willing to be surprised, including by the possibility that nothing much changes. And if something does shift, hold it lightly. Ask whether it is the substance, the ritual, the increased self-attention, or some combination of all three. You may never know for certain, and that is fine.
What matters is that you are paying attention to your own life with more care than you were before. If microdosing helps you do that, wonderful. If something else does it better, that is wonderful too.
References
- Szigeti, B. et al.. Self-blinding citizen science to explore psychedelic microdosing. eLife, 10, e62878.
Disclaimer: This content is for educational and self-reflection purposes only. It is not medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making changes to your health practices.